97
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

A Novel Network Pharmacology Strategy Based on the Universal Effectiveness-Common Mechanism of Medical Herbs Uncovers Therapeutic Targets in Traumatic Brain Injury

, , , , ORCID Icon, , , , ORCID Icon & ORCID Icon show all
Pages 1175-1188 | Received 05 Dec 2023, Accepted 10 Apr 2024, Published online: 16 Apr 2024

References

  • Maas A, Fitzgerald M, Gao G, et al. Traumatic brain injury over the past 20 years: research and clinical progress. Lancet Neurol. 2022;21:768–770. doi:10.1016/S1474-4422(22)00307-6
  • Lee B, Leem J, Kim H, et al. Herbal medicine for acute management and rehabilitation of traumatic brain injury. Medicine. 2019;98:e14145. doi:10.1097/MD.0000000000014145
  • Sawmiller D, Li S, Shahaduzzaman M, et al. Luteolin reduces Alzheimer’s disease pathologies induced by traumatic brain injury. Int J Mol Sci. 2014;15:895–904. doi:10.3390/ijms15010895
  • Wu A, Yong Y, Pan Y, et al. Targeting nrf2-mediated oxidative stress response in traumatic brain injury: therapeutic perspectives of phytochemicals. Oxid Med Cell Longev. 2022;2022:1–24. doi:10.1155/2022/3027514
  • Salem M, Shaheen M, Tabbara A, Borjac J. Saffron extract and crocin exert anti-inflammatory and anti-oxidative effects in a repetitive mild traumatic brain injury mouse model. Sci Rep. 2022;12:5004. doi:10.1038/s41598-022-09109-9
  • Shi Y, Zhou X, Yang R, Ying S, Wang L. Panax notoginseng protects the rat brain function from traumatic brain injury by inhibiting autophagy via mammalian targeting of rapamycin. Aging. 2021;13:11207–11217. doi:10.18632/aging.202790
  • Hu X, Qi C, Feng F, et al. Combining network pharmacology, RNA-seq, and metabolomics strategies to reveal the mechanism of cimicifugae rhizoma - smilax glabra Roxb herb pair for the treatment of psoriasis. Phytomedicine. 2022;105:154384. doi:10.1016/j.phymed.2022.154384
  • Jafari M, Wang Y, Amiryousefi A, Tang J. Unsupervised learning and multipartite network models: A promising approach for understanding traditional medicine. Front Pharmacol. 2020;11:1319. doi:10.3389/fphar.2020.01319
  • Guo F, Tang X, Zhang W, et al. Exploration of the mechanism of traditional Chinese medicine by AI approach using unsupervised machine learning for cellular functional similarity of compounds in heterogeneous networks, XiaoErFuPi granules as an example. Pharmacol Res. 2020;160:105077. doi:10.1016/j.phrs.2020.105077
  • Li T, Zhang W, Hu E, et al. Integrated metabolomics and network pharmacology to reveal the mechanisms of hydroxysafflor yellow A against acute traumatic brain injury. Comput Struct Biotechl J. 2021;19:1002–1013. doi:10.1016/j.csbj.2021.01.033
  • Hu E, Li T, Li Z, et al. Metabolomics reveals the effects of hydroxysafflor yellow A on neurogenesis and axon regeneration after experimental traumatic brain injury. Pharm Biol. 2023;61:1054–1064. doi:10.1080/13880209.2023.2229379
  • Hu E, Li Z, Li T, et al. A novel microbial and hepatic biotransformation-integrated network pharmacology strategy explores the therapeutic mechanisms of bioactive herbal products in neurological diseases: the effects of astragaloside IV on intracerebral hemorrhage as an example. Chin Med. 2023;18:40. doi:10.1186/s13020-023-00745-5
  • Xu J, Wang H, Ding K, et al. Luteolin provides neuroprotection in models of traumatic brain injury via the nrf2–are pathway. Free Radic Biol Med. 2014;71:186–195. doi:10.1016/j.freeradbiomed.2014.03.009
  • Chin C, Chen S, Wu H, Ho C, Ko M, Lin C. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11. doi:10.1186/1752-0509-8-S4-S11
  • Yang Z, Guo Q, Wang Y, et al. Azd3759, a BBB-penetrating EGFR inhibitor for the treatment of EGFR mutant NSCLC with CNS metastases. Sci Transl Med. 2016;8:368ra172. doi:10.1126/scitranslmed.aag0976
  • Zhang Y, Sloan SA, Clarke LE, et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron. 2016;89:37–53. doi:10.1016/j.neuron.2015.11.013
  • Mcgovern AJ, Barreto GE. Network pharmacology identifies il6 as an important hub and target of tibolone for drug repurposing in traumatic brain injury. Biomed Pharmacother. 2021;140:111769. doi:10.1016/j.biopha.2021.111769
  • Lupo G, Gioia R, Nisi PS, Biagioni S, Cacci E. Molecular mechanisms of neurogenic aging in the adult mouse subventricular zone. J Exp Neurosci. 2019;13:1509773112. doi:10.1177/1179069519829040
  • Zhang S, Ju P, Tjandra E, Yeap Y, Owlanj H, Feng Z. Inhibition of epidermal growth factor receptor improves myelination and attenuates tissue damage of spinal cord injury. Cell Mol Neurobiol. 2016;36:1169–1178. doi:10.1007/s10571-015-0313-4
  • Goldshmit Y, Schokoroy Trangle S, Afergan F, Iram T, Pinkas-Kramarski R. Nucleolin inhibitor groa triggers reduction in epidermal growth factor receptor activation: pharmacological implication for glial scarring after spinal cord injury. J Neurochem. 2016;138:845–858. doi:10.1111/jnc.13730
  • Li Z, Li J, Wang L, et al. Epidermal growth factor receptor inhibitor ameliorates excessive astrogliosis and improves the regeneration microenvironment and functional recovery in adult rats following spinal cord injury. J Neuroinflam. 2014;11:71. doi:10.1186/1742-2094-11-71
  • Li Z, Tang R, Zhang J, et al. Inhibiting epidermal growth factor receptor attenuates reactive astrogliosis and improves functional outcome after spinal cord injury in rats. Neurochem Int. 2011;58:812–819. doi:10.1016/j.neuint.2011.03.007
  • Okada S, Hara M, Kobayakawa K, Matsumoto Y, Nakashima Y. Astrocyte reactivity and astrogliosis after spinal cord injury. Neurosci Res. 2018;126:39–43. doi:10.1016/j.neures.2017.10.004
  • Li H, Pan Y, Sun Z, Sun Y, Yang X, Feng D. Inhibition of mir-21 ameliorates excessive astrocyte activation and promotes axon regeneration following optic nerve crush. Neuropharmacology. 2018;137:33–49. doi:10.1016/j.neuropharm.2018.04.028
  • Hara M, Kobayakawa K, Ohkawa Y, et al. Interaction of reactive astrocytes with type I collagen induces astrocytic scar formation through the integrin–n-cadherin pathway after spinal cord injury. Nat Med. 2017;23:818–828. doi:10.1038/nm.4354
  • Tavassoly O, Del Cid Pellitero E, Larroquette F, et al. Pharmacological inhibition of brain EGFR activation by a BBB-penetrating inhibitor, AZD3759, attenuates α-synuclein pathology in a mouse model of α-synuclein propagation. Neurotherapeutics. 2021;18:979–997. doi:10.1007/s13311-021-01017-6
  • Ahn M, Kim D, Cho BC, et al. Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study. Lancet Respir Med. 2017;5:891–902. doi:10.1016/S2213-2600(17)30378-8
  • Zeng Q, Wang J, Cheng Z, et al. Discovery and evaluation of clinical candidate azd3759, a potent, oral active, central nervous system-penetrant, epidermal growth factor receptor tyrosine kinase inhibitor. J Med Chem. 2015;58:8200–8215. doi:10.1021/acs.jmedchem.5b01073
  • Yin W, Zhang K, Deng Q, et al. Azd3759 inhibits glioma through the blockade of the epidermal growth factor receptor and janus kinase pathways. Bioengineered. 2021;12:8679–8689. doi:10.1080/21655979.2021.1991160
  • Chu Q, Wu T, Fu L, Ye J. Simultaneous determination of active ingredients in erigeron breviscapus (vant.) Hand-mazz. By capillary electrophoresis with electrochemical detection. J Pharm Biomed Anal. 2005;37:535–541. doi:10.1016/j.jpba.2004.11.018
  • Lee JY, Chang EJ, Kim HJ, Park JH, Choi SW. Antioxidative flavonoids from leaves of carthamus tinctorius. Arch Pharm Res. 2002;25:313–319. doi:10.1007/BF02976632
  • Xiong Y, Zhong W, Liu J, et al. Luteolin isolated from Polygonum cuspidatum is a potential compound against nasopharyngeal carcinoma. Biomed Res Int. 2022;2022:1–21.
  • Ye B, Chen P, Lin C, Zhang C, Li L. Study on the material basis and action mechanisms of sophora davidii (franch.) skeels flower extract in the treatment of non-small cell lung cancer. J Ethnopharmacol. 2023;317:116815. doi:10.1016/j.jep.2023.116815
  • Wu H, Mahmood A, Lu D, et al. Attenuation of astrogliosis and modulation of endothelial growth factor receptor in lipid rafts by simvastatin after traumatic brain injury. J Neurosurg. 2010;113:591–597. doi:10.3171/2009.9.JNS09859
  • Zhou Y, Shao A, Yao Y, Tu S, Deng Y, Zhang J. Dual roles of astrocytes in plasticity and reconstruction after traumatic brain injury. Cell Commun Signal. 2020;18:62. doi:10.1186/s12964-020-00549-2